全文获取类型
收费全文 | 19369篇 |
免费 | 2655篇 |
国内免费 | 397篇 |
专业分类
耳鼻咽喉 | 151篇 |
儿科学 | 1104篇 |
妇产科学 | 505篇 |
基础医学 | 1642篇 |
口腔科学 | 279篇 |
临床医学 | 2313篇 |
内科学 | 5768篇 |
皮肤病学 | 381篇 |
神经病学 | 1394篇 |
特种医学 | 460篇 |
外国民族医学 | 13篇 |
外科学 | 2561篇 |
综合类 | 1215篇 |
现状与发展 | 1篇 |
一般理论 | 5篇 |
预防医学 | 1639篇 |
眼科学 | 773篇 |
药学 | 855篇 |
2篇 | |
中国医学 | 204篇 |
肿瘤学 | 1156篇 |
出版年
2024年 | 57篇 |
2023年 | 462篇 |
2022年 | 323篇 |
2021年 | 510篇 |
2020年 | 498篇 |
2019年 | 237篇 |
2018年 | 806篇 |
2017年 | 781篇 |
2016年 | 853篇 |
2015年 | 826篇 |
2014年 | 748篇 |
2013年 | 1021篇 |
2012年 | 1262篇 |
2011年 | 1294篇 |
2010年 | 940篇 |
2009年 | 910篇 |
2008年 | 1005篇 |
2007年 | 1027篇 |
2006年 | 868篇 |
2005年 | 949篇 |
2004年 | 1375篇 |
2003年 | 1269篇 |
2002年 | 914篇 |
2001年 | 824篇 |
2000年 | 331篇 |
1999年 | 341篇 |
1998年 | 373篇 |
1997年 | 305篇 |
1996年 | 154篇 |
1995年 | 104篇 |
1994年 | 90篇 |
1993年 | 116篇 |
1992年 | 105篇 |
1991年 | 54篇 |
1990年 | 61篇 |
1989年 | 61篇 |
1988年 | 61篇 |
1987年 | 46篇 |
1986年 | 39篇 |
1985年 | 28篇 |
1984年 | 20篇 |
1983年 | 20篇 |
1982年 | 19篇 |
1981年 | 26篇 |
1980年 | 15篇 |
1977年 | 13篇 |
1975年 | 15篇 |
1974年 | 18篇 |
1968年 | 17篇 |
1928年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
Zhan Mingshu You Yucai Jia HuachengXu Zhao Wei Rongjun Huo WeiyangJiang Qingtao Department Neurosurgery the First Hospital Beijing Medical University Dept. Neurosurg. P. L. A. Hosp. of Beijing. Dept. Orthopedics P. L. A. Hosp. of Beijing 《北京大学学报(医学版)》1989,(4)
Omentum transposition to cervical spinal cord for the treatment of traumatic cervical spinal cord myelopathy.In treating spinal cord injury, the clinic of cervical spinal cord injury has to face the problems of tetraplegia and control of Respiration. The application of various kins of treatment include skull traction, laminectomy, intervebral bone graft fusion and omen turn spinal cord transposition. We have treated 10 cases in the period from June, 1986 to June, 1983. The discussion will focus on the Oinentum transposition to cervical spinal cord and the related problems of cervical spinal cord injury. 相似文献
72.
本文报告用罐头瓶药膜法和点滴法对实验室饲养的3日龄未吸血印鼠客蚤为试验对象,测试了溴氰菊酯、滴滴畏、久效磷、磷胺、喹硫磷、倍硫磷半数致死量(LD_(50))和半数致死浓度(LC_(50))。结果以溴氰菊酯和喹硫磷的LC_(50)值较低,磷胺和滴滴畏的数值较高,LD_(50)以溴氰菊酯和倍硫磷毒力较强,磷胺和久效磷次之,雌雄个体差异不明显。 相似文献
73.
Petra M.C. Callenbach Lise P.M. Pels Paul G.H. Mulder Wim H.J.P. Linssen Rob H.J.M. Gooskens Jan L. van der Zwan Oebele F. Brouwer For the SUM Trial Group 《European journal of paediatric neurology》2007,11(6):325-330
About 4-10% of children and adolescents suffer from migraine. In the last few years, several studies have been performed to assess the efficacy and safety of triptans for the acute treatment of migraine in children and adolescents. Only sumatriptan nasal spray has been approved for the treatment of acute migraine with or without aura in adolescents aged 12-17 years in Europe. This review describes the results of the studies with sumatriptan nasal spray that have been performed in children and adolescents, including a study performed in the Netherlands. 相似文献
74.
75.
Kensei Minoda 《眼科学报》1996,(1)
Purpose: To disclose the structure of visual pigment gene for a protanopia with specific variation.Methods: Exon 5 fragments of the red andgreen visual pigment genes from the protanopia with specific varnation as well as controls were amplified by poly-merase chain reaction (PCR). The PCR products were put through heteroduplex-SSCP analysis and PCR-RFLP (restriction fragement length polymorphism) analysis to clarify the specific variation. The specific variation of the exon 5 DNA fragment from the protanopia was identified by sequencing.Results: A novel 5'green-3'red hybrid gene fragment without the normal red and green visual pigment gene was discovered in the protanopia. He should only have a single visual pigment gene, 5'green-3'red hybrid gene, on his X chromosome. The fusion point is between codon 285 and codon 296 in exon 5. Conclusion : Unequal intragenic recombination may occur in exon 5 as well as its upstream. A 5'green-3'red hybrid gene may present independently on the X chromosome without ac 相似文献
76.
A. C. KEECH J. M. ARMITAGE K. R. WALLENDSZUS A. LAWSON A. J. HAUER S. E. PARISH R. COLLINS for the Oxford Cholesterol Study Group 《British journal of clinical pharmacology》1996,42(4):483-490
1It has been suggested that lipophilic HMG CoA reductase inhibitors, like lovastatin and simvastatin, may cause sleep disturbance.
2Six hundred and twenty-one patients at increased risk of coronary heart disease were randomized in a single centre to receive 40 mg daily simvastatin, 20 mg daily simvastatin or matching placebo. To assess the effects of prolonged use of simvastatin on nocturnal sleep quality and duration, a sleep questionnaire was administered to 567 patients (95% of 595 survivors) at an average of 88 weeks (range: 44–129 weeks) after randomization.
3The main outcome measures were sleep-related problems and use of sleep-enhancing medications reported during routine study follow-up visits, and responses to the sleep questionnaire about changes in sleep duration and about various sleep events during the preceding month.
4No differences were observed between the treatment groups in the frequency of sleep-related problems reported, in the proportion of follow-up visits at which such problems were reported, or in the use of sleep-enhancing medications. The numbers who stopped study treatment were similar in the different treatment groups, and no patient stopped principally because of insomnia. In response to the sleep questionnaire, there were no significant differences between the treatment groups in reports of various sleep events during the preceding month, except that slightly fewer patients allocated simvastatin reported waking often. No differences in sleep duration were observed.
5This placebo-controlled trial does not indicate any adverse effects of prolonged treatment with simvastatin on systematically sought measures of sleep disturbance. 相似文献
77.
Schmidt S.; Giessel R.; Bergis K. H.; Strojek K.; Grzeszczak W.; Ganten D.; Ritz E.; the Diabetic Nephropathy Study Group 《Nephrology, dialysis, transplantation》1996,11(9):1755-1761
BACKGROUND.: There is agreement that a family history of hypertension (HT),is a predictor for the risk of diabetic nephropathy (DN) inpatients with type 2 diabetes, and possibly also type 1 diabetes.It follows that genes related to the risk of hypertension mustalso be considered candidate genes for DN. The 235T allele ofthe angiotensinogen gene was found to be related to primaryHT. METHODS.: To examine whether it is predictive for DN as well, we examinedthe angiotensinogen gene polymorphism in 230 healthy local controls,423 patients with type 1 diabetes (n=180 with DN; n=243 withoutDN) and 663 patients with type 2 diabetes (n=310 with DN; n=353without DN). The angiotensinogen gene M235T polymorphism wasdetermined using PCR amplification. RESULTS.: The following results were obtained (i) no significant differenceof genotype distribution (type 1: MM/MT/TT(%) 27.6/57.2/15.2vs. 27.2/56.1/16.7 (P=0.92); type 2: MM/MT/TT (%) 31.7/48.2/20.1vs. 32.9/46.8/20.3 (P=0.93)) or allele frequencies (type 1:M 0.56 vs. 0.55 (P=0.795); type 2: M 0.56 vs. 0.56 (P=0.86))was found, between diabetic patients with or without DN, (ii)no difference was found between normotensive and hypertensivediabetic patients. CONCLUSION.: The data argue against a role of the angiotensinogen gene M235Tpolymorphism in the manifestation of diabetic nephropathy orhypertension in diabetic patients. 相似文献
78.
79.
用国产WD-L92型染料激光机,对56例,61眼施行激光虹膜透切术。其中40眼行周边虹膜透切术,完全切穿率为92.5%;9例白内障术后瞳孔上移行光学虹膜切除术疗效满意。对其它一些病例也取得一定疗效。认为染料激光具有输出功率大,能量及光斑可调的优点,易一次击穿虹膜,应用于虹膜透切术疗效肯定。 相似文献
80.
Siddharth K. Prakash Soniely Lugo‐Ruiz Michelle Rivera‐Dávila Nunilo Rubio Jr. Avni N. Shah Rebecca C. Knickmeyer Cindy Scurlock Melissa Crenshaw Shanlee M. Davis Gary A. Lorigan Aaron T. Dorfman Karen Rubin Cheryl Maslen Vaneeta Bamba Paul Kruszka Michael Silberbach Scientific Advisory Board of the TSRR 《American journal of medical genetics. Part C, Seminars in medical genetics》2019,181(1):7-12
To address knowledge gaps about Turner syndrome (TS) associated disease mechanisms, the Turner Syndrome Society of the United States created the Turner Syndrome Research Registry (TSRR), a patient‐powered registry for girls and women with TS. More than 600 participants, parents or guardians completed a 33‐item foundational survey that included questions about demographics, medical conditions, psychological conditions, sexuality, hormonal therapy, patient and provider knowledge about TS, and patient satisfaction. The TSRR platform is engineered to allow individuals living with rare conditions and investigators to work side‐by‐side. The purpose of this article is to introduce the concept, architecture, and currently available content of the TSRR, in anticipation of inviting proposals to utilize registry resources. 相似文献